Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 172, Issue -, Pages 104616

出版商

Elsevier BV

发表日期

2019-09-27

DOI

10.1016/j.antiviral.2019.104616

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now